{
    "Trade/Device Name(s)": [
        "Wortham Laboratories Stasis 1 Coagulation Control (Normal)",
        "Wortham Laboratories Stasis 2 Coagulation Control (Abnormal)",
        "Wortham Laboratories Stasis 3 Coagulation Control (Abnormal)",
        "Wortham Laboratories Serathan-B PT Reagent",
        "Wortham Laboratories Serathan-A PT Reagent",
        "Wortham Laboratories Intrin-EA APTT Reagent",
        "Wortham Laboratories Intrin-SI APTT Reagent",
        "Wortham Laboratories Fibrinogen Control Plasma (Low)",
        "Wortham Laboratories Fibrinogen Control Plasma (Normal)",
        "Wortham Laboratories Thrombin Reagent",
        "Wortham Laboratories Heparin Control Plasma Level 1",
        "Wortham Laboratories Heparin Control Plasma Level 2",
        "Wortham Laboratories Calcium Chloride Solution 0.02 M",
        "Wortham Laboratories Fibrinogen Assay Set",
        "Wortham Laboratories Fibrinogen Buffer"
    ],
    "Submitter Information": "Wortham Laboratories, Inc.",
    "510(k) Number": "K060968",
    "Predicate Device Reference 510(k) Number(s)": [
        "K984129",
        "K984130",
        "K984131",
        "K994100",
        "K940082",
        "K891337",
        "K023362",
        "K800826",
        "K970645",
        "K992278",
        "K992279"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GIZ",
        "GGC",
        "GGN",
        "GJS",
        "GFO",
        "GIL",
        "KQJ",
        "GHH"
    ],
    "Summary Letter Date": "May 15, 2007",
    "Summary Letter Received Date": "April 9, 2007",
    "Submission Date": "April 6, 2007",
    "Regulation Number(s)": [
        "21 CFR 864.5425",
        "21 CFR 864.7750",
        "21 CFR 864.7925",
        "21 CFR 864.7340"
    ],
    "Regulation Name(s)": [
        "Multipurpose System for in vitro coagulation studies",
        "Prothrombin Time Test",
        "Activated Partial Thromboplastin",
        "Fibrinogen Determination System"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "Prothrombin Time (PT)",
        "Activated Partial Thromboplastin Time (APTT)",
        "Fibrinogen",
        "Factors II",
        "Factors V",
        "Factors VII",
        "Factors X",
        "Factors VIII",
        "Factors IX",
        "Factors XI",
        "Factors XII",
        "Heparin",
        "Calcium Chloride"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Citrated tube"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Coagulation assay",
        "Thromboplastin reagent",
        "Thrombin reagent",
        "Calcium chloride activation"
    ],
    "Methodologies": [
        "Clot formation measurement",
        "Quality control plasma",
        "Factor assay",
        "Diluent (buffer) for fibrinogen studies"
    ],
    "Submission Type(s)": [
        "Control",
        "Reagent",
        "Buffer",
        "Assay Set",
        "Solution"
    ],
    "Document Summary": "FDA 510(k) summary for Wortham Laboratories multipanel coagulation controls, PT/APTT/thrombin/fibrinogen/heparin reagents and control plasmas for in vitro diagnostic coagulation monitoring",
    "Indications for Use Summary": "Used as quality controls, reagents, buffers, and assay components for monitoring and measuring PT, APTT, fibrinogen, heparin, and clotting factors in plasma for clinical laboratory coagulation studies",
    "fda_folder": "Hematology"
}